CUI · 44755338 · J161198/2023 · DOLJ

HESY BIOTECH CONSULTING S.R.L.

Str. SCORPIONII AURII, Nr. 39
Rast, DOLJ, 207490

DizolvarePJ

ANAF Live Status

Synced 20d ago
RADIERE din data 07.05.2025RADIERE din data 07.05.2025
VAT payerNoNe-plătitor TVA
Cash VATNo
Split VATNo
e-FacturaNo

Source: ANAF PlatitorTvaRest v9 (public API · no auth · daily sync). Covers VAT registration, cash-basis VAT, split-payment VAT, e-Factura enrollment, and fiscal inactivity.

People

2 representatives
Sign in to reveal
  • B🇷🇴

    B**** A****

    Administrator
  • B🇷🇴

    B**** A****

    Administrator

Revenue · 2024

53.0K RON

-35%

Net Profit · 2024

-7.1K RON

-129%

Employees · 2024

1

+0%

Equity · 2024

766 RON

-99%

Registration

Trade Register:J161198/2023
Registered:12.04.2025 12:18:54
Unit type:Sediu central

Contact

Phone:0767561113

Tax Status

Non-VATIMP100

Address

Rast

DOLJ

207490

Financial Health Score

43/100
Grey zoneWorsening

Altman Z″ inputs · 2024

WC / TA
0.32
RE / TA
0.02
EBIT / TA
0.00
Eq / Liab
0.02
How is this calculated?

We apply the Altman Z″, a bankruptcy-prediction score published by Edward Altman for private, non-manufacturing companies. It combines four ratios — each captures a different aspect of financial health — and weights them:

Z″ = 6.56·X1 + 3.26·X2 + 6.72·X3 + 1.05·X4
  • X1 — Working Capital / Total Assets · short-term liquidity.
  • X2 — Retained Earnings / Total Assets · cumulative profitability.
  • X3 — EBIT / Total Assets · operating efficiency.
  • X4 — Equity / Total Liabilities · solvency buffer.

Thresholds (Altman, 2000): Distress < 1.1, Grey 1.1–2.6, Safe > 2.6.

The 0–100 score is a linear mapping of clamped Z″ in the [0, 5] range — a visual shorthand, not an additional metric. Hover any year on the chart to see the per-year breakdown.

Caveats: Romanian bilanț doesn't split liabilities into short/long-term, so we approximate current liabilities as 0.7·I7 (SME heuristic). EBIT is approximated with I16 (gross profit), since interest is bundled into I15.

Z″ over time

Distress < 1.1 · Caution 1.1–2.6 · Safe > 2.6

Financial Performance

14 years of reporting

All figures sourced from ANAF and Ministerul Finanțelor filings. Click any data point to explore.

2011 — 2024

Net turnover (revenue) & Net Profit

Assets × Liabilities

Balance Sheet Overview

Revenues vs expenses

Total revenues vs Total expenses

Since 2016

Avg. number of employees

Year 2024

Asset Breakdown

Raw Data

Raw Financial Data

YearNet turnover (revenue)Net profitTotal liabilitiesFixed assetsCurrent assetsShareholders' equityAvg. number of employeesInventoriesReceivablesCash & bank accountsPrepaid expensesDeferred revenueProvisionsPaid-in share capitalState patrimonyTotal revenuesTotal expensesGross profitGross lossNet loss
2024
53.000
-35.0%
0
-100.0%
30.772
+715.2%
31.538
-54.2%
766
-99.0%
1
+0.0%
31.538
-54.2%
200
+0.0%
53.000
-35.0%
59.549
+6.1%
0
-100.0%
6.549
7.079
2023
81.600
+34.9%
24.642
-47.0%
3.775
+44.8%
8.735
+2964.9%
68.886
+33.7%
73.846
+50.1%
1
68.886
+33.8%
200
+0.0%
81.600
+34.9%
56.142
+344.3%
25.458
-46.8%
0
0
2022
60.476
46.513
2.607
285
51.526
49.204
0
0
28
51.498
0
0
0
200
0
60.476
12.636
47.840
0
0
HESY BIOTECH CONSULTING S.R.L. · CUI 44755338 | entitate